Pernix Therapeutics Holdings, Inc.
(NASDAQ : PTX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading PTX News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
-2.41%16.1810.2%$210.07m
SHPGShire PLC Sponsored ADR
-2.24%181.290.3%$191.23m
PRGOPerrigo Co. Plc
0.40%84.414.3%$132.58m
MNKMallinckrodt Plc
-2.00%53.3811.1%$108.85m
MDCOMedicines Company
0.42%52.0619.0%$105.28m
ENDPEndo International Plc
-1.79%13.159.0%$90.85m
PRXLPAREXEL International Corporation
0.09%65.947.5%$85.48m
UTHRUnited Therapeutics Corporation
-0.50%146.7112.7%$84.75m
ICPTIntercept Pharmaceuticals, Inc.
2.81%119.1921.9%$71.58m
JAZZJazz Pharmaceuticals Plc
0.52%136.112.3%$64.77m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.45%123.7410.9%$47.54m
SAGESAGE Therapeutics, Inc.
-0.05%62.3012.1%$46.23m
PTLAPortola Pharmaceuticals, Inc.
4.17%33.508.8%$43.98m
HZNPHorizon Pharma plc
1.75%17.4511.1%$41.47m
SGYPSynergy Pharmaceuticals, Inc.
0.18%5.4916.1%$39.93m

Company Profile

Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. The firm distributes its products under the following brands: Treximet, Silenor, Zohydro ER with BeadTek, and Khedezla. The company was founded on March 9, 2010 and is headquartered in The Woodlands, TX.